Effectiveness and safety of reduced dose prasugrel versus standard dose ticagrelor in East Asian patients with acute coronary syndrome undergoing percutaneous coronary intervention

被引：0
|
作者：
Huang, Hsin-Yi [1 ]
Wang, Chi-Chuan [1 ]
Wu, Yee-Jen [2 ]
Wu, Chien-Chih [2 ]
Huang, Ling-Ya [1 ]
机构：
[1] Natl Taiwan Univ, Sch Pharm, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Pharm, Taipei, Taiwan
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
53
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [21] Prasugrel versus ticagrelor in patients with acute coronary syndrome undergoing percutaneous coronary intervention; a meta-analysis of randomized controlled trials
    Rodriguez, Z.
    Valdecanas, A.
    Palileo, N.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1465 - 1465
  • [22] Efficacy and safety of ticagrelor and clopidogrel in East Asian patients with coronary artery disease undergoing percutaneous coronary intervention
    Li, Jianan
    Qiu, Hong
    Yan, Lirong
    Guo, Tingting
    Wang, Yong
    Li, Yang
    Zheng, Jianfeng
    Tang, Yida
    Xu, Bo
    Qiao, Shubin
    Yang, Yuejin
    Gao, Runlin
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (11) : 1739 - 1745
  • [23] Comparative Efficacy and Safety of Prasugrel, Ticagrelor, and Standard-Dose and High-Dose Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis
    Singh, Sukhchain
    Singh, Mukesh
    Grewal, Navsheen
    Khosla, Sandeep
    AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (01) : E52 - E62
  • [24] Reduced versus Standard Dose Apixaban in Patients With Atrial Fibrillation and Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial
    Fudim, Marat
    Lopes, Renato D.
    Wojdyla, Daniel M.
    Mehran, Roxana
    Khan, Mohammad S.
    Granger, Christopher B.
    Goodman, Shaun G.
    Aronson, Ron
    Windecker, Stephan
    Alexander, John H.
    CIRCULATION, 2022, 146
  • [25] Efficacy and Safety of Low-Dose Prasugrel Versus Clopidogrel in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a Systematic Review and Meta-analysis
    Yuttana Wongsalap
    Supakorn Ungsriwong
    Wanalee Kumtep
    Surasak Saokaew
    Vichai Senthong
    Kirati Kengkla
    Cardiovascular Drugs and Therapy, 2022, 36 : 991 - 1000
  • [26] Efficacy and Safety of Low-Dose Prasugrel Versus Clopidogrel in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a Systematic Review and Meta-analysis
    Wongsalap, Yuttana
    Ungsriwong, Supakorn
    Kumtep, Wanalee
    Saokaew, Surasak
    Senthong, Vichai
    Kengkla, Kirati
    CARDIOVASCULAR DRUGS AND THERAPY, 2022, 36 (05) : 991 - 1000
  • [27] DIFFERENTIAL USE BETWEEN PRASUGREL AND TICAGRELOR IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN ROUTINE PRACTICE
    Effron, Mark B.
    Molife, Cliff
    Karkare, Swapna
    Larmore, Cynthia
    Zhu, Yajun
    Lee, Won Chan
    Frech-Tamas, Feride
    Lieu, Hsiao
    DeKoven, Mitch
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A225 - A225
  • [28] Comparative efficacy & safety of Prasugrel, Ticagrelor, standard & high dose Clopidogrel in patients undergoing percutaneous coronary intervention (PCI): A network meta-analysis
    Singh, Sukhchain
    Singh, Mukesh
    Grewal, Navsheen
    Khosla, Sandeep
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B79 - B80
  • [29] Efficacy and Safety of Prasugrel Compared With Clopidogrel for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Wang, Amy
    Lella, Leela K.
    Brener, Sorin J.
    AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (06) : E1637 - E1643
  • [30] Safety and Effectiveness of Rivaroxaban in Patients with Acute Coronary Syndrome undergoing Percutaneous Coronary Intervention
    Li Xiaoyan
    Lu Ying
    Zhang Er Hong
    Zhang Ping
    Zhang Ping
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (16) : C150 - C150
12345